• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症诊断与治疗的神经肌肉并发症

Neuromuscular complications of cancer diagnosis and treatment.

作者信息

Falah Mohamed, Schiff David, Burns Ted M

机构信息

Department of Neurology, University of Virginia, Charlottesville 22908, USA.

出版信息

J Support Oncol. 2005 Jul-Aug;3(4):271-82.

PMID:16092597
Abstract

Neuromuscular disorders are a common cause of morbidity in patients with cancer. They can be a direct effect of the primary malignancy, a paraneoplastic effect, or a treatment complication. Malignant neoplasms may infiltrate or compress nerve roots, plexi, and peripheral nerves, causing various sensory and motor symptoms. Electrodiagnostic testing, cerebrospinal fluid analysis, and neuroimaging are helpful in confirming the diagnosis. Treatment for neuropathies of neoplastic origin involves irradiation and chemotherapy, which may improve pain, but usually does not improve neurologic function. Paraneoplastic syndromes are rare and sometimes result from production of autoantibodies directed against neural antigens present in tumor tissues. They commonly precede any symptoms related to the cancer itself, and discovery of such syndromes necessitates a thorough investigation to look for an occult neoplasm. Treatment of the underlying cancer occasionally improves neurologic function. Both brachial and lumbosacral plexopathies may represent a complication of radiotherapy. Electrodiagnostic tests particularly are helpful; these diagnostics demonstrate the presence of myokymic discharges, which are suggestive of radiation injury. Many chemotherapeutic agents may cause peripheral neurotoxicity and associated acute and chronic peripheral neuropathies, particularly if given to patients with preexisting hereditary or acquired neuropathies. These side effects are a limiting factor in cancer treatment. Other potential neuromuscular problems related to cancer include side effects of steroids and other immunosuppressants, effects secondary to bone marrow transplantation, and infections. Early recognition and management of these disorders will improve patient outcome and quality of life.

摘要

神经肌肉疾病是癌症患者发病的常见原因。它们可能是原发性恶性肿瘤的直接影响、副肿瘤效应或治疗并发症。恶性肿瘤可能浸润或压迫神经根、神经丛和周围神经,导致各种感觉和运动症状。电诊断测试、脑脊液分析和神经影像学有助于确诊。肿瘤源性神经病变的治疗包括放疗和化疗,这可能会改善疼痛,但通常不会改善神经功能。副肿瘤综合征很少见,有时是由针对肿瘤组织中存在的神经抗原产生自身抗体引起的。它们通常先于任何与癌症本身相关的症状出现,发现此类综合征需要进行彻底检查以寻找隐匿性肿瘤。治疗潜在的癌症偶尔会改善神经功能。臂丛和腰骶丛神经病变都可能是放疗的并发症。电诊断测试尤其有用;这些诊断显示存在肌束震颤放电,提示放射损伤。许多化疗药物可能会导致周围神经毒性以及相关的急性和慢性周围神经病变,特别是给予已有遗传性或获得性神经病变的患者时。这些副作用是癌症治疗的一个限制因素。与癌症相关的其他潜在神经肌肉问题包括类固醇和其他免疫抑制剂的副作用、骨髓移植的继发效应以及感染。早期识别和处理这些疾病将改善患者的预后和生活质量。

相似文献

1
Neuromuscular complications of cancer diagnosis and treatment.癌症诊断与治疗的神经肌肉并发症
J Support Oncol. 2005 Jul-Aug;3(4):271-82.
2
Neuromuscular complications of systemic cancer.
Neurol Clin. 1991 Nov;9(4):901-18.
3
Neuropathies associated with malignancy.与恶性肿瘤相关的神经病变
Semin Neurol. 1998;18(1):125-44. doi: 10.1055/s-2008-1040868.
4
Neuromuscular disorders in systemic malignancy and its treatment.
Muscle Nerve. 1995 Jun;18(6):636-48. doi: 10.1002/mus.880180611.
5
Paraneoplastic peripheral neuropathy.
Baillieres Clin Neurol. 1995 Nov;4(3):443-68.
6
Paraneoplastic syndromes.副肿瘤综合征
Neurol Clin. 1991 Nov;9(4):919-36.
7
Neuromuscular complications of cancer and cancer treatments.
Phys Med Rehabil Clin N Am. 2008 Feb;19(1):27-45, v-vi. doi: 10.1016/j.pmr.2007.10.001.
8
Neuromuscular syndromes associated with malignant disease.
Br J Hosp Med. 1977 Apr;17(4):356, 360-2.
9
Neoplastic and paraneoplastic synovitis.肿瘤性和副肿瘤性滑膜炎。
Rheum Dis Clin North Am. 2011 Nov;37(4):551-72. doi: 10.1016/j.rdc.2011.09.008.
10
Management of chronic pain in cancer survivors.癌症幸存者慢性疼痛的管理。
Cancer J. 2008 Nov-Dec;14(6):401-9. doi: 10.1097/PPO.0b013e31818f5aa7.